MRKR Marker Therapeutics, Inc.
$1.15▼ -4.17%
Healthcare
Other
After hours
$1.21▲ +5.22%
Sep 11, 5:56 PM ET
Volume 59.4K
Avg Volume (10D) 76.3K
Key Metrics & Fundamentals
Market Cap
$19.17M
P/E Ratio
–
Div Yield
–%
52W Range
0.84 - 2.46
% vs 50 MA
-10.84%
% vs 200 MA
-20.13%
RSI-14
41.3
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$3.72M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.94M
COGS
–
Operating Exp
$1.94M
Operating Income
-$1.94M
EBIT
-$1.94M
Pretax Income
-$1.83M
Net Income
-$1.83M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
Zacks · Aug 6, 2026 1:50 PM
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
Zacks · Jun 26, 2026 8:59 AM
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Zacks · Jun 25, 2026 12:40 PM
Exploring 3 High Growth Tech Stocks in US Market
Simply Wall St. · Jun 15, 2026 11:39 AM
Financial Overview - Income Statement
Quarterly
Dec 2024
See MRKR's money flow as a full page
Social Sentiment
No Reddit posts found for MRKR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.